De novo missense variants in the RAP1B gene identified in two patients with syndromic thrombocytopenia
JH Niemann, C Du, S Morlot, G Schmidt… - Clinical …, 2020 - Wiley Online Library
JH Niemann, C Du, S Morlot, G Schmidt, B Auber, B Kaune, G Göhring, T Ripperger…
Clinical Genetics, 2020•Wiley Online LibraryWe present two independent cases of syndromic thrombocytopenia with multiple
malformations, microcephaly, learning difficulties, dysmorphism and other features. Exome
sequencing identified two novel de novo heterozygous variants in these patients, c. 35G> T
p.(Gly12Val) and c. 178G> C p.(Gly60Arg), in the RAP1B gene (NM_001010942. 2). These
variants have not been described previously as germline variants, however functional
studies in literature strongly suggest a clinical implication of these two activating hot spot …
malformations, microcephaly, learning difficulties, dysmorphism and other features. Exome
sequencing identified two novel de novo heterozygous variants in these patients, c. 35G> T
p.(Gly12Val) and c. 178G> C p.(Gly60Arg), in the RAP1B gene (NM_001010942. 2). These
variants have not been described previously as germline variants, however functional
studies in literature strongly suggest a clinical implication of these two activating hot spot …
Abstract
We present two independent cases of syndromic thrombocytopenia with multiple malformations, microcephaly, learning difficulties, dysmorphism and other features. Exome sequencing identified two novel de novo heterozygous variants in these patients, c.35G>T p.(Gly12Val) and c.178G>C p.(Gly60Arg), in the RAP1B gene (NM_001010942.2). These variants have not been described previously as germline variants, however functional studies in literature strongly suggest a clinical implication of these two activating hot spot positions. We hypothesize that pathogenic missense variants in the RAP1B gene cause congenital syndromic thrombocytopenia with a spectrum of associated malformations and dysmorphism, possibly through a gain of function mechanism.
